Exploring the efficacy of a novel cannabidiol and bevacizumab combination in non-small cell lung cancer
{{output}}
Background: Lung cancer remains the leading cause of cancer-related mortality worldwide. Despite advances in therapeutic strategies, the 5-year survival rate for patients with non-small cell lung cancer (NSCLC) remains approximat... ...
